What cancers explain the growing rural‐urban gap in human papillomavirus‐associated cancer incidence?
The Journal of Rural Health,
Journal Year:
2025,
Volume and Issue:
41(1)
Published: Jan. 1, 2025
Human
papillomavirus
(HPV)
can
cause
cancers
of
the
genital
system,
anus/rectum,
and
oropharynx.
Prior
research
showed
that
HPV-associated
cancer
incidence
was
rising
faster
in
nonmetro
than
metro
populations.
Our
study
identified
which
contributed
to
widening
disparity.
Language: Английский
Influence of the COVID-19 pandemic on the incidence and mortality of primary spinal tumors in the United States: A SEER analysis
European Spine Journal,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 31, 2025
Language: Английский
Impact of Presurgical Second‐Touch Visits on Delays in Initiating Adjuvant Radiation Therapy
Otolaryngology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 10, 2025
Abstract
Objective
Patients
with
head
and
neck
squamous
cell
carcinoma
(HNSCC)
often
encounter
delays
in
starting
postoperative
radiotherapy
(PORT),
leading
to
worse
outcomes.
We
investigated
whether
attending
second‐touch
visits—appointments
after
the
initial
clinic
visit
before
surgery
address
treatment‐related
questions
follow‐up
expectations—with
an
advanced
practice
provider
(APP)
is
associated
reduced
PORT
delays.
Study
Design
Retrospective
cohort
study.
Setting
Single
tertiary
referral
center.
Methods
Adult
patients
HNSCC
who
underwent
free
flap
between
2020
2022
were
included.
All
offered
a
visit.
The
primary
outcome
was
delay,
defined
as
treatment
initiation
>42
days
surgery.
Clinicodemographic
data
collected
at
baseline
last
known
follow‐up.
Results
Of
104
included,
57.7%
attended
Attendance
receiving
(RT)
academic
setting
(65.0%
vs
40.9%,
P
=
.015)
fewer
(56.7%
79.5%,
.015).
Multivariable
analysis
revealed
70%
reduction
odds
of
delay
for
those
visits
(adjusted
ratio
[aOR]
0.298,
95%
CI
0.103‐0.866,
.026).
more
likely
RT
community
(aOR
3.783,
1.284‐11.146,
.016),
wound
complications
5.149,
1.363‐19.460,
higher
comorbidity
index
1.407,
1.012‐1.957,
.042).
Conclusion
medical
center
significantly
likelihood
delay.
These
findings
underscore
importance
APP‐driven
patient
navigation
improving
timely
care
outcomes
HNSCC.
Language: Английский
Análisis de la supervivencia de los pacientes con tumores malignos de cabeza y cuello diagnosticados durante la pandemia de COVID-19
Acta Otorrinolaringológica Española,
Journal Year:
2025,
Volume and Issue:
76(2), P. 106 - 115
Published: Feb. 16, 2025
Differences in the incidence and mortality of tracheal, bronchus, and lung cancer between the Global Cancer Observatory 2022 and the Global Burden of Disease 2021
Journal of the National Cancer Center,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 1, 2025
Language: Английский
The COVID‐19 pandemic and associated declines in cancer incidence by race/ethnicity and census‐tract level SES, rurality, and persistent poverty status
Benmei Liu,
No information about this author
Mandi Yu,
No information about this author
Jeffrey Byrne
No information about this author
et al.
Cancer Medicine,
Journal Year:
2024,
Volume and Issue:
13(17)
Published: Sept. 1, 2024
The
COVID-19
pandemic
had
a
significant
impact
on
cancer
screening
and
treatment,
particularly
in
2020.
However,
no
single
study
has
comprehensively
analyzed
its
effects
incidence
disparities
among
groups
such
as
race/ethnicity,
socioeconomic
status
(SES),
persistent
poverty
(PP),
rurality.
Language: Английский
The Effect of Coronavirus Disease 2019 and Other Emerging Infections on Dentistry
Dental Clinics of North America,
Journal Year:
2024,
Volume and Issue:
68(4), P. 627 - 646
Published: Sept. 6, 2024
Language: Английский
Nasopharyngeal, tongue and laryngeal cancer in Southern Ethiopia: a seven-year retrospective cross-sectional review
ecancermedicalscience,
Journal Year:
2024,
Volume and Issue:
18
Published: Oct. 8, 2024
The
burden
of
cancer
is
increasing
globally
and
having
a
negative
impact
on
people's
physical,
mental
financial
health.
On
the
other
hand,
developing
countries
are
not
progressing
to
prevent
disease
at
same
rate
as
increases.
development
strategies
for
prevention,
control
treatment
that
contribute
community's
improved
health
requires
knowledge
epidemiologic
data.
There
relatively
little
evidence
nasopharyngeal,
tongue
laryngeal
in
southern
Ethiopia.
This
study
aimed
assess
epidemiological
among
patients
treated
Hawassa
University
Comprehensive
Specialised
Hospital
(HUCSH)
between
2013
2019.
A
cross-sectional
retrospective
review
was
conducted
3,002
who
attended
oncologic
care
HUCSH.
Data
were
retrieved
February
May
2020.
entered
using
Epi-data
version
3.1
data
then
exported
IBM
SPSS
22
(IBM
Corporation,
Armonk,
NY,
USA)
further
processing
analysis.
descriptive
analysis
done.
total
280
(9.3%)
new
head
neck
(HNC)
identified
over
period
7
years.
Nasopharyngeal
accounts
more
than
one-fourth
(26.4%)
all
HNCs,
followed
by
15%
14.6%
cancers.
Males
constituted
nearly
two-thirds
cases.
overall
caseloads
doubled
According
this
study,
prominent
cause
morbidity.
place,
person
time,
frequency
steadily
rose
both
sexes
across
age
categories.
Therefore,
immediate
intervention
needed
nationwide
monitor
disease's
explosive
growth.
Language: Английский
Impact of Symptom Distress on the Quality of Life of Oncology Palliative Care Patients: A Portuguese Cross-Sectional Study
Healthcare,
Journal Year:
2024,
Volume and Issue:
12(23), P. 2487 - 2487
Published: Dec. 9, 2024
Uncontrolled
symptoms
are
widely
recognized
as
one
of
the
main
challenges
in
oncology
palliative
care
patients.
The
central
aim
is
to
improve
patient's
quality
life.
In
recent
years,
there
has
been
a
growing
use
patient-reported
outcome
measures
care,
particularly
evaluate
symptoms,
and
well-being.
Language: Английский
Comparing Cisplatin Dosing Schedules in Concurrent Chemoradiotherapy for Locally Advanced Head-and-Neck Cancer: A Comprehensive Review of Weekly Versus 3-Weekly Regimens
Oscar Chi-Yu Yang,
No information about this author
Nai-Wen Su,
No information about this author
Yi‐Shing Leu
No information about this author
et al.
Journal of Cancer Research and Practice,
Journal Year:
2024,
Volume and Issue:
11(4), P. 125 - 133
Published: Oct. 1, 2024
Abstract
Objective:
There
are
approximately
900,000
new
cases
of
head-and-neck
cancer
(HNC)
annually,
with
a
significant
proportion
presenting
as
locally
advanced
(LA-HNC).
Cisplatin-based
concurrent
chemoradiotherapy
(CCRT)
has
become
widely
accepted,
particularly
for
patients
deemed
inoperable.
The
standard
regimen
is
high-dose
3-weekly
cisplatin
schedule,
however,
this
can
lead
to
considerable
toxicities.
This
review
evaluates
the
efficacy,
safety,
and
compliance
associated
an
emerging
alternative:
weekly
dosing
schedule.
Data
Sources:
current
literature
included
randomized
controlled
trials,
meta-analyses,
retrospective
studies
within
past
decade,
comparing
weekly,
CCRT
regimens
LA-HNC.
Study
Selection:
Studies
cisplatin-based
were
included.
Results:
Weekly
demonstrated
comparable
efficacy
traditional
lower
toxicity
improved
compliance.
Key
suggested
that
may
have
more
favorable
safety
profile,
reduced
risks
neutropenia,
renal
impairment,
ototoxicity.
However,
potential
slightly
better
locoregional
control
remains
point
ongoing
investigation.
Novel
agents
including
immune
checkpoint
inhibitors,
xevinapant,
berzosertib
being
actively
investigated
combinational
therapies
CCRT.
Conclusion:
viable
alternative
treating
LA-HNC,
in
at
higher
risk
Further
trials
required
confirm
optimal
schedule
novel
agents.
These
findings
underline
importance
exploring
treatment
protocols
balance
therapeutic
benefits
adverse
effects
Language: Английский